H Grant Skaggs Jr

Array ( [id] => 9107162 [patent_doc_number] => 20130280294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'BOVINE VIRAL DIARRHEA VIRUS TYPE 1B VACCINE COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/995688 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33621 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209040 [patent_doc_number] => 20120128706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'IMMUNE ADJUVANT COMPRISING ATP' [patent_app_type] => utility [patent_app_number] => 13/316800 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5121 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128706.pdf [firstpage_image] =>[orig_patent_app_number] => 13316800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11762271 [patent_doc_number] => 09370563 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-21 [patent_title] => 'Newcastle disease virus and the use thereof as a vaccine' [patent_app_type] => utility [patent_app_number] => 13/988046 [patent_app_country] => US [patent_app_date] => 2011-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6230 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9401159 [patent_doc_number] => 08691209 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Packaging of immunostimulatory substances into virus-like particles: method of preparation and use' [patent_app_type] => utility [patent_app_number] => 13/294006 [patent_app_country] => US [patent_app_date] => 2011-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 108 [patent_no_of_words] => 51311 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13294006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9560706 [patent_doc_number] => 20140178419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPS)' [patent_app_type] => utility [patent_app_number] => 13/883745 [patent_app_country] => US [patent_app_date] => 2011-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13193 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138623 [patent_doc_number] => 20120093863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'HCV VACCINES AND METHODS FOR USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/278160 [patent_app_country] => US [patent_app_date] => 2011-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12783 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093863.pdf [firstpage_image] =>[orig_patent_app_number] => 13278160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9875548 [patent_doc_number] => 08962816 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Constructs for enhancing immune responses' [patent_app_type] => utility [patent_app_number] => 13/239771 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 42 [patent_no_of_words] => 21646 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 224 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13239771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8975973 [patent_doc_number] => 20130209403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'USE OF INHIBITORS OF PHOSPHOLIPASE A2 FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 13/819380 [patent_app_country] => US [patent_app_date] => 2011-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8275 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9383407 [patent_doc_number] => 20140086888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'EBV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR THE TREATMENT OF LOCOREGIONAL NASOPHARYNGEAL CARCINOMA (NPC)' [patent_app_type] => utility [patent_app_number] => 13/820169 [patent_app_country] => US [patent_app_date] => 2011-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7454 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9983123 [patent_doc_number] => 09028827 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Compositions and methods for treating hepatitis virus infection' [patent_app_type] => utility [patent_app_number] => 13/197110 [patent_app_country] => US [patent_app_date] => 2011-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5224 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13197110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8767100 [patent_doc_number] => 20130095137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'PAN-LYSSAVIRUS VACCINES AGAINST RABIES' [patent_app_type] => utility [patent_app_number] => 13/806622 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16976 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7783858 [patent_doc_number] => 20120045414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'ADJUVANT COMBINATIONS COMPRISING A MICROBIAL TLR AGONIST, A CD40 OR 4-1BB AGONIST, AND OPTIONALLY AN ANTIGEN AND THE USE THEREOF FOR INDUCING A SYNERGISTIC ENHANCEMENT IN CELLULAR IMMUNITY' [patent_app_type] => utility [patent_app_number] => 13/164853 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7582 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20120045414.pdf [firstpage_image] =>[orig_patent_app_number] => 13164853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650901 [patent_doc_number] => 20110300170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'HCV VACCINES' [patent_app_type] => utility [patent_app_number] => 13/110468 [patent_app_country] => US [patent_app_date] => 2011-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14558 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300170.pdf [firstpage_image] =>[orig_patent_app_number] => 13110468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650900 [patent_doc_number] => 20110300169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING AN ANTIGEN' [patent_app_type] => utility [patent_app_number] => 13/110454 [patent_app_country] => US [patent_app_date] => 2011-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4378 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300169.pdf [firstpage_image] =>[orig_patent_app_number] => 13110454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754683 [patent_doc_number] => 20120027795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'SIMPLE VACCINES FROM DNA LAUNCHED SUICIDAL FLAVIVIRUSES' [patent_app_type] => utility [patent_app_number] => 13/104909 [patent_app_country] => US [patent_app_date] => 2011-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 23593 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027795.pdf [firstpage_image] =>[orig_patent_app_number] => 13104909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8915957 [patent_doc_number] => 20130177582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'PARAPOXVIRUS EXPRESSING THE VP60 MAJOR CAPSID PROTEIN OF THE RABBIT HAEMORRHAGIC DISEASE VIRUS' [patent_app_type] => utility [patent_app_number] => 13/643547 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 6861 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13643547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11643318 [patent_doc_number] => 09664684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-30 [patent_title] => 'Methods of treating cancer using chemovirotherapy' [patent_app_type] => utility [patent_app_number] => 13/643962 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3402 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13643962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8184185 [patent_doc_number] => 20120114674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'Molecular Antigen Array' [patent_app_type] => utility [patent_app_number] => 13/096970 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 85289 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13096970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7566991 [patent_doc_number] => 20110287054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'MULTIVALENT ADJUVANTED INFLUENZA VIRUS COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/096180 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 47962 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287054.pdf [firstpage_image] =>[orig_patent_app_number] => 13096180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064535 [patent_doc_number] => 20110201676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'METHOD OF TREATING INFLAMMATORY ARTHROPATHIES WITH SUPPRESSORS OF CPG OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/093725 [patent_app_country] => US [patent_app_date] => 2011-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 17363 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201676.pdf [firstpage_image] =>[orig_patent_app_number] => 13093725 [rel_patent_id] =>[rel_patent_doc_number] =>)